Strides Pharma Inc. has initiated a voluntary nationwide recall of more than 89,000 bottles of children’s liquid ibuprofen after receiving complaints of a gel-like mass and black particles in the medication.
The recall, which began on March 2, affects Children’s Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle.
The product was manufactured in India for Taro Pharmaceuticals U.S.A.
Consumers can identify affected bottles using the following details:
Product: Children’s Ibuprofen Oral Suspension, USP
Strength: 100 mg per 5 mL
Size: 4 FL OZ (120 mL)
Lot numbers: 7261973A, 7261974A
Expiration date: Jan. 31, 2027
The U.S. Food and Drug Administration classified the recall as Class II, meaning that use of the product may cause temporary or medically reversible adverse health effects with a low risk of serious consequences.
This product has a recall number of D-0390-2026.
It affects 89,592 bottles.